Related Experiment Video
Updated: May 22, 2026

Proximal Cadaveric Femur Preparation for Fracture Strength Testing and Quantitative CT-based Finite Element Analysis
Published on: March 11, 2017
Femoral bone is preserved using cemented polished stems in young patients
Donald W Howie1, Kerry Costi, Margaret A McGee
1Department of Orthopaedics and Trauma, Royal Adelaide Hospital, L4 Bice Building, North Terrace, Adelaide, SA 5000, Australia. donald.howie@adelaide.edu.au
Background:
Techniques that ensure femoral bone preservation after primary THA are important in younger patients who are likely to undergo revision surgery.
Questions/Purposes:
We examined femoral stem survival, bone deficiency at revision arthroplasty, and radiographic bone loss in hips implanted with a cemented polished double-taper stem in a cohort of patients younger than 55 years.
Methods:
We reviewed 197 hips (median patient age, 47 years; range, 16-54 years) after a minimum followup of 2 years (median, 7 years; range, 2-19 years) since primary THA. Clinically, we determined survival to major and minor stem revision and cases of bone deficiency requiring a long stem or impaction bone grafting or created by the need for femoral osteotomy at revision arthroplasty. Radiographically, we assessed stem loosening, femoral osteolysis, and femoral bone deficiency.
Results:
Stem survival to major revision for aseptic loosening was 100% at 13 years and for any reason was 97% (95% CI, 93-100%). At revision of seven stems, a long stem was used in one hip, a total femoral replacement in one hip and impaction bone grafting in one hip. No femoral osteotomies were required. Bone was preserved in four hips by cement-within-cement stem exchange. No stems were radiographically loose. Proximal osteolysis was present in 11% of femurs. Femoral bone deficiency was graded as Paprosky Type I (97%) or II (3%) and Endo-Klinik Grade 0 (79%) or I (21%).
Conclusions:
Cemented polished taper stems have high survival at 13 years in young patients and enable femoral bone preservation for subsequent revision.
Level Of Evidence:
Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.

